anagrelide
anagrelide is listed in the FDA National Drug Code directory with 2 NDC codes, marketed under brand name including anagrelide. Available dosage form: capsule.
Drug Details
- Generic Name
- anagrelide
- Brand Names
- anagrelide
- Application Number
- ANDA209151
- Sponsor
- Torrent Pharmaceuticals Limited
- NDC Codes
- 2
- Dosage Forms
- CAPSULE
- Routes
- ORAL
- Active Ingredients
- ANAGRELIDE HYDROCHLORIDE ANHYDROUS
Indications and Usage
1 INDICATIONS AND USAGE AGRYLIN is indicated for the treatment of patients with thrombocythemia, secondary to myeloproliferative neoplasms, to reduce the elevated platelet count and the risk of thrombosis and to ameliorate associated symptoms including thrombo-hemorrhagic events. AGRYLIN is a platelet reducing agent indicated for the treatment of thrombocythemia, secondary to myeloproliferative neoplasms, to reduce the elevated platelet count and the risk of thrombosis and to ameliorate associated symptoms including thrombo-hemorrhagic events. ( 1 )